Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden response rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-01T14:45:41.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T13:52:00.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:18:55.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:55:47.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    DENIVOS study page now renders a 403 Forbidden error, replacing the usual detailed study information with an error view. The content sections such as history, eligibility criteria, and outcome measures are no longer visible.
    Difference
    17%
    Check dated 2026-09-20T19:41:56.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A funding attribution for 2018 (NIH grant/contract) was added, and the page revision label was updated from v3.6.5 to v3.6.6 to reflect the current version.
    Difference
    0.1%
    Check dated 2026-08-30T06:44:38.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.